Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

TSHA-102 from Taysha gets rare paediatric disease and orphan drug designations for Rett syndrome

expresspharmaOctober 16, 2020

Tag: TSHA-102 , Taysha , gene therapy , Rett syndrome

PharmaSources Customer Service